Shares in mid-cap pharma company Angle fell nearly 12 per cent on Wednesday after it missed market expectations for revenue and continued to be loss-making. Revenue for the full year …
Estate Planning
Sketch: ITV leaders debate was political ‘pinball machine’
The wall of noise and jeers in the Commons chamber must have felt like comforting, familiar territory to them both, compared to the glare of the ITV primetime spotlight. Just …
Sour year for VK and Hooch maker as price rises fail to offset costs jump
The maker of alcoholic drinks such as VK and Hooch saw its profit slashed as its costs surged despite the group raising prices. Global Brands, which is headquartered in Derbyshire, …
Interest rate cuts edge closer after ‘very encouraging’ inflation news
The Bank of England received encouraging news on the persistence of inflation today after a closely watched business survey showed cost pressures were decisively easing. S&P’s closely watched purchasing managers’ …
Deal that values Globaldata arm at over £1bn nears completion
A deal which valued the division of international data and analytics firm Globaldata at more than £1bn is to be completed later this month, it has been confirmed. In December 2023, private …
Octopus Energy inks landmark agreement with Gresham House Energy Storage Fund
Gresham House Energy Storage Fund has announced a landmark agreement with Octopus Energy, one of the UK’s largest and fastest-growing energy suppliers. The energy storage fund owns a portfolio of …
Jupiter extends the exit of star fund manager
City investment house Jupiter has extended the exit of its star fund manager Ben Whitmore today after the announcement of his departure wiped millions from the company’s valuation in January. …
Former cyber security boss ‘believes a Russian group’ is behind the NHS ‘major IT incident’
A leading cyber security expert has warned Russia was behind this week’s hack of NHS services, which caused a “major IT incident”. The former chief executive of the National Cyber …
Astrazeneca swallows up Canada-based Fusion Pharmaceuticals in £1.5bn move
Astrazeneca has completed its $2bn (£1.5bn) acquisition of Canada-based Fusion Pharmaceuticals. The deal was first announced in March for the business which develops so-called next-generation radioconjugates (RCs) – complex drugs which, when fully …
Workspace: Flexible office provider calls market bottom as workers return to the City
Flexible office provider Workspace said its “future is bright” after it revealed a 8.7 per cent increase in profit for the year to March. The FTSE 250 company said demand …